Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.
Biomedicines（2023）
摘要
Our data suggest a new strategy of combining eribulin with PI3K or mTOR inhibitors to treat TNBC.
更多查看译文
关键词
copanlisib,eribulin,everolimus,the PI3K/mTOR pathway,triple-negative breast cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要